<DOC>
	<DOC>NCT01000987</DOC>
	<brief_summary>The purpose of this study is the examine the effect of varenicline on reactivity to a high dose (0.08 g/dL) of alcohol (vs. placebo alcohol) over the ascending and descending limb of the blood alcohol curve.</brief_summary>
	<brief_title>Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders</brief_title>
	<detailed_description />
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>21 years old or older Able to read and write in English Smokers and nonsmokers Meet criteria for alcohol use disorders Currently enrolled in NCT00580645 Any significant current medical or psychiatric conditions that would contraindicate the consumption of alcohol Significant hepatocellular injury Positive test results at intake appointments on urine drug screens conducted for opiates, cocaine, or benzodiazepines Women who are pregnant or nursing Suicidal, homicidal, or evidence of severe mental illness Prescription of any psychotropic drug in the 30 days prior to study enrollment Blood donation within the past 8 weeks Individuals who are seeking treatment for drinking or smoking or who have attempted to quit drinking or smoking within the past 3 months Known allergy to varenicline or taking H2blockers Participation within the past 8 weeks in other studies that involve additive blood sampling and/or interventional measures that would be considered excessive in combination with the current protocol Subjects likely to exhibit clinically significant alcohol withdrawal during the study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>alcohol</keyword>
	<keyword>reactivity</keyword>
	<keyword>smoking cessation medications</keyword>
</DOC>